Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.
Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.
Multus Media enables cultivated meat companies to scale affordably and profitably. We take care of the growth media, so our customers can focus on bringing delicious, sustainable meat to the world. Taking a machine learning-based approach we can design a completely animal-free growth media that is tailored for animal cells. This is particularly useful for the cultivated meat industry where there are needs of high performance at large scale. Multus Media was established in 2019 and is headquartered in London, England.
Sava is a company focused on advancing biosensing technology to enhance personal health monitoring. By providing real-time feedback on the body's molecular signature, particularly for athletes, Sava's technology allows for continuous and effortless monitoring of crucial metrics such as glucose and lactate levels. This capability enables athletes to train more effectively, predict fatigue, and optimize their dietary plans. Sava's innovative approach aims to make health information more accessible, delivering insights in a painless and affordable manner, thereby redefining how individuals interact with their health.
Samphire Neuroscience is a neurotechnology company based in London, England, founded in 2021. The company focuses on women's health and lifestyle enhancement through innovative solutions. Its primary product is a headband device that employs non-invasive electrical neuromodulation to stimulate specific areas of the brain. This technology aims to alleviate symptoms commonly associated with menstrual cycles, including pain, fatigue, and mood disturbances, thereby improving the overall well-being of women.
Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Our co-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. The team has grown to contain commercial expertise that encompasses individuals with a unicon exit in their CV's, as well as multiple startup experience between them. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.
Aksense is an innovative company focused on developing affordable and portable nucleic acid-based diagnostic panels for the rapid and accurate detection of pathogens. Its flagship product is the first portable rapid infection diagnostic biosensor designed to improve healthcare quality and safety. By facilitating early detection and treatment of infections, Aksense's technology aims to enhance antibiotic prescribing practices and reduce the spread of infections. This approach not only improves patient outcomes but also supports public health initiatives by allowing users to recover faster through cost-effective molecular testing solutions.
Carv is the first wearable dedicated to skiing that speaks to you as you ski - it’s your digital ski coach. Built in consultation with Olympians, Carv gives you access to the feedback and knowledge that only elite skiers have had access to so far. With an extremely thin smart insert, Carv measures your motion and pressure distribution and relays feedback through your earphones in real-time. Carv connects wirelessly to your smartphone to give simple, actionable feedback to casual skiers and detailed metrics and analysis for advanced and professional skiers. Carv lets you train, compete and challenge people with its detailed metrics and helps you improve your skiing with technique analysis.
Unicorn Biotechnologies is developing a fully automated manufacturing platform to enable cellular agriculture producers to seamlessly scale products from the lab bench to supermarket shelves. Our full stack platform combines hardware, software and analytics to completely automate cellular agriculture manufacturing, reducing costs and increasing product quality. By providing a clear path to scale cellular agriculture from grams to tons, we will improve human and planetary health and drive the transition to animal free agriculture.
AromatEco assists household brands in becoming more environmentally friendly by delivering renewable flavors and perfumes. Headquartered in London, UK.
AromatEco assists household brands in becoming more environmentally friendly by delivering renewable flavors and perfumes. Headquartered in London, UK.
VemiCo is a biotechnology company focused on extending healthy living by addressing the aging process. It utilizes artificial intelligence and synthetic biology to identify and develop promising molecules derived from gut microbial DNA. This innovative approach allows medical professionals to leverage the benefits of microbiomes, promoting gut health and enhancing overall well-being.
Samphire Neuroscience is a neurotechnology company based in London, England, founded in 2021. The company focuses on women's health and lifestyle enhancement through innovative solutions. Its primary product is a headband device that employs non-invasive electrical neuromodulation to stimulate specific areas of the brain. This technology aims to alleviate symptoms commonly associated with menstrual cycles, including pain, fatigue, and mood disturbances, thereby improving the overall well-being of women.
Reach Industries focuses on developing cutting-edge products for companies. Reach Industries was founded in 2020 and was headquartered in Bristol, UK.
Asset Direct, founded in 2015 and based in London, Ontario, is a financial solutions company that specializes in connecting consumers with poor credit to various loan organizations. The company has developed an online personal loan search platform that facilitates instant approval credit from providers and offers on-the-spot financing options for consumers. Additionally, Asset Direct supports both large business owners and small local shop owners by providing an agent network that enables them to launch and build businesses focused on selling financial products and services. Through its innovative approach, Asset Direct aims to improve access to financing for individuals and businesses alike.
Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.
CoffeeExchange is a digital platform based in Shanghai, China, that connects coffee farmers directly with roasters, aiming to enhance transparency in the coffee industry. Established in 2018, the company utilizes technology to streamline the green coffee trading process, offering services such as coffee evaluation, logistics, customs clearance, quality inspections, and marketing support. By eliminating intermediaries, CoffeeExchange facilitates direct trade, allowing coffee producers to earn significantly higher revenues while providing roasters with a broader selection at reduced costs. The platform incorporates IoT supply chain tracking and freight consolidation to optimize logistics and enhance order management. Currently, CoffeeExchange has over 1,100 coffee roasters in China trading with selected producers from various countries, including Ethiopia, Rwanda, Ecuador, Colombia, Guatemala, and El Salvador, and is in the process of expanding its operations to the USA, UK, and South Korea.
Kyomei is a company based in Oxford, England, that focuses on developing a plant-based production system aimed at creating animal proteins for the alternative meat industry. Founded in 2021, Kyomei utilizes plant cell biology to enhance the flavor of meat alternatives by scaling the production of myoglobin in plants, which contributes to the umami taste. This innovative approach not only aims to improve the sensory experience of plant-based meats but also seeks to reduce the environmental impact associated with traditional animal farming. By providing consumers with flavorful plant-based meat options, Kyomei positions itself as a key player in the growing alternative meat market.
Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.
Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.
Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.
Circadia fuses light science with sleep science to help adjust your body clock. Their flagship products include a non-contact sleep tracker for sleep diagnostics and a portable light therapy device for treatment. The devices sync together for an automatic and customised sleep improvement programme. Team from Imperial College London. Accelerated by HAX. Mentored by Johnson & Johnson Innovation. Launching on Kickstarter in March 2017.
Asset Direct, founded in 2015 and based in London, Ontario, is a financial solutions company that specializes in connecting consumers with poor credit to various loan organizations. The company has developed an online personal loan search platform that facilitates instant approval credit from providers and offers on-the-spot financing options for consumers. Additionally, Asset Direct supports both large business owners and small local shop owners by providing an agent network that enables them to launch and build businesses focused on selling financial products and services. Through its innovative approach, Asset Direct aims to improve access to financing for individuals and businesses alike.
Asset Direct, founded in 2015 and based in London, Ontario, is a financial solutions company that specializes in connecting consumers with poor credit to various loan organizations. The company has developed an online personal loan search platform that facilitates instant approval credit from providers and offers on-the-spot financing options for consumers. Additionally, Asset Direct supports both large business owners and small local shop owners by providing an agent network that enables them to launch and build businesses focused on selling financial products and services. Through its innovative approach, Asset Direct aims to improve access to financing for individuals and businesses alike.
Asset Direct, founded in 2015 and based in London, Ontario, is a financial solutions company that specializes in connecting consumers with poor credit to various loan organizations. The company has developed an online personal loan search platform that facilitates instant approval credit from providers and offers on-the-spot financing options for consumers. Additionally, Asset Direct supports both large business owners and small local shop owners by providing an agent network that enables them to launch and build businesses focused on selling financial products and services. Through its innovative approach, Asset Direct aims to improve access to financing for individuals and businesses alike.
Kutanios is a biotechnology firm focused on creating new compounds for anti-aging, sun care, anti-acne, and skin cleaning items. Headwuartered in London.
Kutanios is a biotechnology firm focused on creating new compounds for anti-aging, sun care, anti-acne, and skin cleaning items. Headwuartered in London.
Untap Water provides wastewater data to support community health. Headquartered in London.
Multus Media enables cultivated meat companies to scale affordably and profitably. We take care of the growth media, so our customers can focus on bringing delicious, sustainable meat to the world. Taking a machine learning-based approach we can design a completely animal-free growth media that is tailored for animal cells. This is particularly useful for the cultivated meat industry where there are needs of high performance at large scale. Multus Media was established in 2019 and is headquartered in London, England.
Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Our co-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. The team has grown to contain commercial expertise that encompasses individuals with a unicon exit in their CV's, as well as multiple startup experience between them. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.
Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.
Caura is the payment platform for your car to manage parking, tolls, congestion charge, MOTs, vehicle tax, and insurance. Caura Protect is an FCA registered product with seven insurers, allowing drivers to purchase and manage motor insurance. Caura Maintain seamlessly manages MOTs and vehicle servicing.
Verifoxx is a London-based company established in 2019 that specializes in AIoT blockchain technology to facilitate secure and efficient identity verification. Its platform includes a mobile application that allows individuals to use a single set of documents for identity verification across various businesses without disclosing personal information or card details. This privacy-first approach enables consumers to verify their identities easily while maintaining control over their sensitive data. Verifoxx's innovative software not only streamlines the identity verification process but also supports the management of digital assets and transactions, enhancing security for both consumers and businesses.
Multus Media enables cultivated meat companies to scale affordably and profitably. We take care of the growth media, so our customers can focus on bringing delicious, sustainable meat to the world. Taking a machine learning-based approach we can design a completely animal-free growth media that is tailored for animal cells. This is particularly useful for the cultivated meat industry where there are needs of high performance at large scale. Multus Media was established in 2019 and is headquartered in London, England.
Neurocess specializes in wearable technology designed to enhance training performance and minimize injury risks for professional athletes. The company develops attachable sensors that monitor muscle activity during training sessions. These sensors capture critical data on muscle balance, contraction rates, fatigue levels, injury risks, and dehydration. By providing this valuable information, Neurocess enables coaches and athletes to optimize training efficiency and implement preventative measures against injuries.
Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.
Developer of a real-time hydration biosensor platform designed to monitor human bodies at a molecular level. The company's platform is a wearable, non-invasive patch that captures an athlete's sweat and interprets key bio-markers in real-time, starting with electrolytes and total body fluid loss, enabling users to get personalized recommendations that help them improve their performance.
Unicorn Biotechnologies is developing a fully automated manufacturing platform to enable cellular agriculture producers to seamlessly scale products from the lab bench to supermarket shelves. Our full stack platform combines hardware, software and analytics to completely automate cellular agriculture manufacturing, reducing costs and increasing product quality. By providing a clear path to scale cellular agriculture from grams to tons, we will improve human and planetary health and drive the transition to animal free agriculture.
Contents First is the team behind Tappytoon, the premier digital-first comics platform that has become a daily destination for more than 3 Million readers hailing from over 190 countries. Since January 2019, Tappytoon is the #1 to #5 top Comics app by gross revenue on Google Play and App Store in 90 countries including US, UK, Canada, Australia, Germany, and many more. (source: Google Play, Apple, AppAnnie) The Tappytoon library is now available in English, French, and German, spanning exclusive, licensed hits curated from the largest publishers in Korea and Asia, including Kakao, Haksan, Seoul Media, D&C Media, Mr Blue, Jaedam, Comico as well as K-drama/K-pop tie-ins, TV and game adaptations. Premium paywall & free digital comics are available on Web, iPhone, Android. Among the titles beloved by millions are Solo Leveling, The Abandoned Empress, Light & Shadow, Bloody Sweet, and What's Wrong with Secretary Kim, and many more. Launched in 2016, Tappytoon’s vetted translations and chart-topping smartphone apps offer the best way to read full-color digital manga, manhwa and webtoons while supporting the artists, creators, and storytellers. Tappytoon also produces a number of brand-new original comics with select partners and creators, for print, transmedia, film/tv/ani production, distrib/licensing rights.
Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.
Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.
Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.
Developer of a real-time hydration biosensor platform designed to monitor human bodies at a molecular level. The company's platform is a wearable, non-invasive patch that captures an athlete's sweat and interprets key bio-markers in real-time, starting with electrolytes and total body fluid loss, enabling users to get personalized recommendations that help them improve their performance.
Biomage focuses on single-cell analysis to advance life sciences by providing innovative computational methods to derive insights from biological data. The company has developed the Biomage Single Cell Platform, which allows researchers to efficiently analyze single-cell RNA sequencing data. This platform transforms complex datasets into actionable biological insights, facilitating research in both academia and industry. By streamlining the data analysis process, Biomage empowers scientists to enhance drug target discovery while making the application of advanced sequencing technologies more accessible and cost-effective.
Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms to create innovative plant-inspired proteins, such as brazzein, for applications in the food and beverage industries. Additionally, Magellan Life Sciences offers the XSeed platform, which leverages synthetic biology to advance the development of novel proteins aimed at enhancing the food, health, and nutrition sectors.
Carv is the first wearable dedicated to skiing that speaks to you as you ski - it’s your digital ski coach. Built in consultation with Olympians, Carv gives you access to the feedback and knowledge that only elite skiers have had access to so far. With an extremely thin smart insert, Carv measures your motion and pressure distribution and relays feedback through your earphones in real-time. Carv connects wirelessly to your smartphone to give simple, actionable feedback to casual skiers and detailed metrics and analysis for advanced and professional skiers. Carv lets you train, compete and challenge people with its detailed metrics and helps you improve your skiing with technique analysis.
Aō Air is working to enable those in polluted megacities from Beijing to London to take back the streets. Our patented technology is independently validated to be up to 50x better than leading masks on the market.
Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Our co-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. The team has grown to contain commercial expertise that encompasses individuals with a unicon exit in their CV's, as well as multiple startup experience between them. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.
Arthronica Ltd is a London-based company that develops an artificial intelligence platform focused on patient monitoring and rehabilitation. Founded in 2018, the company specializes in solutions such as skeletal tracking, visual strength assessment, image analysis, and video analysis. Its innovative technology aims to validate algorithms capable of monitoring and predicting key disease activities in chronic rheumatic conditions. Currently, Arthronica is engaged in clinical trials in both the United Kingdom and the United States, further advancing its research and application in the medical field.
Developer of a real-time hydration biosensor platform designed to monitor human bodies at a molecular level. The company's platform is a wearable, non-invasive patch that captures an athlete's sweat and interprets key bio-markers in real-time, starting with electrolytes and total body fluid loss, enabling users to get personalized recommendations that help them improve their performance.
Moona S.A.S., founded in 2016 and based in Paris, France, develops an innovative sleep device designed to enhance sleep quality by regulating head temperature throughout the night. This smart technology adapts to the user's body needs, facilitating quicker and more restful sleep. By focusing on the critical relationship between temperature and sleep, Moona aims to provide a solution for individuals seeking to improve their overall sleep experience.
Non Equity Assistance in 2020
BrightCure Ltd. is a company based in London, United Kingdom, that specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). Founded in 2019, BrightCure addresses the significant challenge of recurrent and difficult-to-treat UTIs, which affect a large portion of the global population, particularly women. Conventional UTI treatments often fall short in effectiveness and can lead to serious side effects, contributing to the rise of antibiotic-resistant infections. The company focuses on leveraging the natural microbiome to eliminate harmful bacteria while restoring beneficial flora. BrightCure's flagship product, a bioactive intimate cream, is designed to enhance the natural immune response and support urinary tract health. The UTI treatment market is projected to grow significantly, reflecting the urgent need for effective solutions. BrightCure has received recognition for its innovative approach, including seed investment from SOSV and accolades in various competitions, underscoring its potential impact in the healthcare sector.
Spintex Engineering Limited, established in 2018 and located in Oxford, United Kingdom, specializes in the production of high-performance silk fibers targeted at the aerospace, automotive, and medical textile industries. The company employs an innovative biomimetic spinning process that utilizes alternative proteins in a water-based solution, significantly reducing energy requirements and enabling the creation of sustainable and cost-effective materials. Spintex’s technology not only supports the development of advanced textiles for various applications but also holds the potential for recycling pre-consumer waste streams, thereby contributing to sustainable practices in the textile industry.
Spintex Engineering Limited, established in 2018 and located in Oxford, United Kingdom, specializes in the production of high-performance silk fibers targeted at the aerospace, automotive, and medical textile industries. The company employs an innovative biomimetic spinning process that utilizes alternative proteins in a water-based solution, significantly reducing energy requirements and enabling the creation of sustainable and cost-effective materials. Spintex’s technology not only supports the development of advanced textiles for various applications but also holds the potential for recycling pre-consumer waste streams, thereby contributing to sustainable practices in the textile industry.
BrightCure Ltd. is a company based in London, United Kingdom, that specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). Founded in 2019, BrightCure addresses the significant challenge of recurrent and difficult-to-treat UTIs, which affect a large portion of the global population, particularly women. Conventional UTI treatments often fall short in effectiveness and can lead to serious side effects, contributing to the rise of antibiotic-resistant infections. The company focuses on leveraging the natural microbiome to eliminate harmful bacteria while restoring beneficial flora. BrightCure's flagship product, a bioactive intimate cream, is designed to enhance the natural immune response and support urinary tract health. The UTI treatment market is projected to grow significantly, reflecting the urgent need for effective solutions. BrightCure has received recognition for its innovative approach, including seed investment from SOSV and accolades in various competitions, underscoring its potential impact in the healthcare sector.
BrightCure Ltd. is a company based in London, United Kingdom, that specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). Founded in 2019, BrightCure addresses the significant challenge of recurrent and difficult-to-treat UTIs, which affect a large portion of the global population, particularly women. Conventional UTI treatments often fall short in effectiveness and can lead to serious side effects, contributing to the rise of antibiotic-resistant infections. The company focuses on leveraging the natural microbiome to eliminate harmful bacteria while restoring beneficial flora. BrightCure's flagship product, a bioactive intimate cream, is designed to enhance the natural immune response and support urinary tract health. The UTI treatment market is projected to grow significantly, reflecting the urgent need for effective solutions. BrightCure has received recognition for its innovative approach, including seed investment from SOSV and accolades in various competitions, underscoring its potential impact in the healthcare sector.
Seaquake Ops LLC is a company that specializes in developing an institutional-grade trading and data processing engine aimed at stabilizing the infrastructure within the digital asset market. Founded in 2018 and based in Boulder, Colorado, Seaquake addresses the challenges of volatility and liquidity that currently plague the cryptocurrency market. The company's platform employs advanced quantitative methodologies and low-latency technology to provide comprehensive solutions designed to enhance trading volume across partner exchanges. By focusing on these critical areas, Seaquake aims to improve market efficiency and fulfill orders that would otherwise remain unexecuted.
Machine Medicine Limited develops a health monitoring system that uses computer vision and artificial intelligence in order to extract health metrics. The system tracks activities, walking patterns, detects falls and disease signs, and alert families when an intervention is needed. The company was founded in 2014 and is headquartered in London, United Kingdom.
Liberum was founded in September 2007 as an investment banking firm based in London, focusing on providing a different style of broking in an industry often criticized for poor treatment of clients and staff. The firm aimed to build trust by understanding client needs and fostering a supportive environment for its employees, encouraging their ideas and professional development. It offered a range of services, including capital raising, initial public offerings, mergers and acquisitions, corporate broking, and investment management, catering to various sectors such as aerospace, agriculture, media, pharmaceuticals, and real estate. Over the years, Liberum expanded its team, adding analysts and sales staff to enhance its coverage and provide innovative insights for investors. However, it has since merged and is no longer active.
Liberum was founded in September 2007 as an investment banking firm based in London, focusing on providing a different style of broking in an industry often criticized for poor treatment of clients and staff. The firm aimed to build trust by understanding client needs and fostering a supportive environment for its employees, encouraging their ideas and professional development. It offered a range of services, including capital raising, initial public offerings, mergers and acquisitions, corporate broking, and investment management, catering to various sectors such as aerospace, agriculture, media, pharmaceuticals, and real estate. Over the years, Liberum expanded its team, adding analysts and sales staff to enhance its coverage and provide innovative insights for investors. However, it has since merged and is no longer active.
HausBots Limited specializes in designing and manufacturing wall-climbing robots aimed at enhancing efficiency in painting and maintenance tasks within various industries. Founded in 2017 and based in Birmingham, United Kingdom, the company has developed a unique wall-climbing robot that can navigate rough surfaces, making it suitable for exterior and warehouse painting, as well as for high-definition visual inspections and infrastructure surveys. This innovative technology enables clients to automate inspections and maintenance at height, thereby increasing productivity and ensuring effective protection and upkeep of the built environment. The company's focus is on utilizing robotics to streamline labor-intensive tasks, particularly for large-scale exterior projects.
Scindo is a cleantech start-up harnessing the power of enzymes to recycle the unrecyclables. We are targeting plastics that cannot be efficiently recycled with current methodologies, to turn them into high-value molecules that can be used in a plethora of industries. We are creating a more circular economy for plastics by developing an alternative to landfills and incineration.
Biomage focuses on single-cell analysis to advance life sciences by providing innovative computational methods to derive insights from biological data. The company has developed the Biomage Single Cell Platform, which allows researchers to efficiently analyze single-cell RNA sequencing data. This platform transforms complex datasets into actionable biological insights, facilitating research in both academia and industry. By streamlining the data analysis process, Biomage empowers scientists to enhance drug target discovery while making the application of advanced sequencing technologies more accessible and cost-effective.
Multus Media enables cultivated meat companies to scale affordably and profitably. We take care of the growth media, so our customers can focus on bringing delicious, sustainable meat to the world. Taking a machine learning-based approach we can design a completely animal-free growth media that is tailored for animal cells. This is particularly useful for the cultivated meat industry where there are needs of high performance at large scale. Multus Media was established in 2019 and is headquartered in London, England.
Multus Media enables cultivated meat companies to scale affordably and profitably. We take care of the growth media, so our customers can focus on bringing delicious, sustainable meat to the world. Taking a machine learning-based approach we can design a completely animal-free growth media that is tailored for animal cells. This is particularly useful for the cultivated meat industry where there are needs of high performance at large scale. Multus Media was established in 2019 and is headquartered in London, England.
Biomage focuses on single-cell analysis to advance life sciences by providing innovative computational methods to derive insights from biological data. The company has developed the Biomage Single Cell Platform, which allows researchers to efficiently analyze single-cell RNA sequencing data. This platform transforms complex datasets into actionable biological insights, facilitating research in both academia and industry. By streamlining the data analysis process, Biomage empowers scientists to enhance drug target discovery while making the application of advanced sequencing technologies more accessible and cost-effective.
Scindo is a cleantech start-up harnessing the power of enzymes to recycle the unrecyclables. We are targeting plastics that cannot be efficiently recycled with current methodologies, to turn them into high-value molecules that can be used in a plethora of industries. We are creating a more circular economy for plastics by developing an alternative to landfills and incineration.
Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.
Contents First is the team behind Tappytoon, the premier digital-first comics platform that has become a daily destination for more than 3 Million readers hailing from over 190 countries. Since January 2019, Tappytoon is the #1 to #5 top Comics app by gross revenue on Google Play and App Store in 90 countries including US, UK, Canada, Australia, Germany, and many more. (source: Google Play, Apple, AppAnnie) The Tappytoon library is now available in English, French, and German, spanning exclusive, licensed hits curated from the largest publishers in Korea and Asia, including Kakao, Haksan, Seoul Media, D&C Media, Mr Blue, Jaedam, Comico as well as K-drama/K-pop tie-ins, TV and game adaptations. Premium paywall & free digital comics are available on Web, iPhone, Android. Among the titles beloved by millions are Solo Leveling, The Abandoned Empress, Light & Shadow, Bloody Sweet, and What's Wrong with Secretary Kim, and many more. Launched in 2016, Tappytoon’s vetted translations and chart-topping smartphone apps offer the best way to read full-color digital manga, manhwa and webtoons while supporting the artists, creators, and storytellers. Tappytoon also produces a number of brand-new original comics with select partners and creators, for print, transmedia, film/tv/ani production, distrib/licensing rights.
Aō Air is working to enable those in polluted megacities from Beijing to London to take back the streets. Our patented technology is independently validated to be up to 50x better than leading masks on the market.
Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.
Aksense is an innovative company focused on developing affordable and portable nucleic acid-based diagnostic panels for the rapid and accurate detection of pathogens. Its flagship product is the first portable rapid infection diagnostic biosensor designed to improve healthcare quality and safety. By facilitating early detection and treatment of infections, Aksense's technology aims to enhance antibiotic prescribing practices and reduce the spread of infections. This approach not only improves patient outcomes but also supports public health initiatives by allowing users to recover faster through cost-effective molecular testing solutions.
eFanswer LTD operates an online platform that facilitates interaction between fans and celebrities. Founded in 2014 and based in London, the platform allows users to ask questions to their favorite idols, discover intriguing insights, and compile their inquiries into a unique e-book. Through this crowd writing approach, celebrities can share their life stories and experiences via text, audio, and video content, enhancing their connection with fans. The service empowers users to engage with their idols in a meaningful way, creating memorable records of their interactions while enabling celebrities to reach a broader audience across various social platforms.
Bubbleye is a rapidly growing AI startup specializing in mobile marketing solutions. With R&D headquarters in Taipei and business development teams operating globally, the company addresses inefficiencies in mobile user acquisition through the use of automation and inferential algorithms. Founded by an international team of AI experts and mobile gaming enthusiasts, Bubbleye boasts a diverse cultural background, drawing talent from Italy, Taiwan, the USA, and the UK. The firm has gained recognition and support from notable investors, including alumni from prominent organizations and accelerators. Its client base includes leading game publishers from the Americas, Europe, and Asia, reflecting its commitment to enhancing mobile marketing performance through innovative technology.
Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Our co-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. The team has grown to contain commercial expertise that encompasses individuals with a unicon exit in their CV's, as well as multiple startup experience between them. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.
Breather Products Inc. is a provider of on-demand private workspaces designed for productivity, allowing clients to reserve and unlock spaces through its web and mobile applications. Founded in 2012 and based in Montreal, Canada, the company has established a network of hundreds of locations across major cities, including New York, San Francisco, Los Angeles, Boston, Chicago, Washington, Toronto, Montreal, and London. Breather offers flexible workspace solutions available by the hour, day, or month, catering to businesses seeking comfortable and private environments. Each space is equipped with technology that facilitates seamless work experiences, enabling users to engage in meetings or video conferences without delay.
Aksense is an innovative company focused on developing affordable and portable nucleic acid-based diagnostic panels for the rapid and accurate detection of pathogens. Its flagship product is the first portable rapid infection diagnostic biosensor designed to improve healthcare quality and safety. By facilitating early detection and treatment of infections, Aksense's technology aims to enhance antibiotic prescribing practices and reduce the spread of infections. This approach not only improves patient outcomes but also supports public health initiatives by allowing users to recover faster through cost-effective molecular testing solutions.
Chemicle is developing a cost effective and clean chemical process to convert dairy waste into bio-plastic precursors. These are the building blocks of high-performance and totally recyclable plastics, whose production could decrease emissions during the manufacturing phase up to 70%.
VemiCo is a biotechnology company focused on extending healthy living by addressing the aging process. It utilizes artificial intelligence and synthetic biology to identify and develop promising molecules derived from gut microbial DNA. This innovative approach allows medical professionals to leverage the benefits of microbiomes, promoting gut health and enhancing overall well-being.
ai nutrition develops an AI that automates online grocery shopping and precision nutrition for better health outcomes.
Arthronica Ltd is a London-based company that develops an artificial intelligence platform focused on patient monitoring and rehabilitation. Founded in 2018, the company specializes in solutions such as skeletal tracking, visual strength assessment, image analysis, and video analysis. Its innovative technology aims to validate algorithms capable of monitoring and predicting key disease activities in chronic rheumatic conditions. Currently, Arthronica is engaged in clinical trials in both the United Kingdom and the United States, further advancing its research and application in the medical field.
Volatile Technologies Ltd, established in 2019 and headquartered in London, UK, specializes in developing innovative artificial intelligence-based portable smell sensors designed for the brewing industry. The company offers a cutting-edge solution that employs multiple layers of machine learning algorithms and unique odor sensor technology to monitor beer aroma at various stages of the brewing process. This technology enables the detection of flavor defects, ensuring consistent responses and enhancing overall panel accuracy in quality control. In addition to its London headquarters, Volatile maintains offices in Shenzhen, China, and Vilnius, Lithuania, further supporting its global reach in the food and beverage production sector.
CorNatural develops bio-based sustainable products to offer a range of natural products. The company aims to upcycle waste streams into value-added products, using pioneering synthetic biology and genetic engineering techniques. CorNatural was founded in 2019 and is headquartered in London.
Rize Health is a virtual marketplace for clinical trials that focuses on enhancing the interaction between patients and researchers. Founded in 2019 and based in London, Ontario, the company offers a patient management platform designed to match individuals with suitable clinical trials while facilitating digital participation. The platform includes features such as onboarding, scheduling, and remote data capture, enabling medical professionals to automate the onboarding process for participants and minimize dropout rates. Through its innovative approach, Rize Health aims to streamline the clinical trial experience for both patients and researchers.
Pushme Inc. is a manufacturer of swappable batteries specifically designed for bicycles, aiming to enhance urban mobility. Founded in 2016 and based in Bath, United Kingdom, the company operates as a subsidiary of Tier Mobility GmbH. Pushme focuses on addressing the challenges of energy distribution for small electric vehicles by establishing a network of battery swap stations. These stations allow local merchants to sell energy, providing convenient and instant recharging solutions across cities. The innovative approach not only supports the adoption of electric bicycles but also empowers individuals with access to electricity to contribute to sustainable transport. The team at Pushme comprises engineers, designers, and operations experts dedicated to developing efficient hardware solutions that improve cycling experiences and facilitate energy management.
Sana Health UK Limited develops a sleep mask for people with severe sleep problems caused by high anxiety or pain. The company offers Sana, a wearable device that allows the wearer to put themselves to sleep in 10 minutes. Its mask measures and tracks user’s overall state of health and vitality over time, and uses this measure to tailor the device to get user to deep relaxation and sleep fast. Sana Health UK Limited was founded in 2015 and is based in Dorchester, United Kingdom.
CoffeeExchange is a digital platform based in Shanghai, China, that connects coffee farmers directly with roasters, aiming to enhance transparency in the coffee industry. Established in 2018, the company utilizes technology to streamline the green coffee trading process, offering services such as coffee evaluation, logistics, customs clearance, quality inspections, and marketing support. By eliminating intermediaries, CoffeeExchange facilitates direct trade, allowing coffee producers to earn significantly higher revenues while providing roasters with a broader selection at reduced costs. The platform incorporates IoT supply chain tracking and freight consolidation to optimize logistics and enhance order management. Currently, CoffeeExchange has over 1,100 coffee roasters in China trading with selected producers from various countries, including Ethiopia, Rwanda, Ecuador, Colombia, Guatemala, and El Salvador, and is in the process of expanding its operations to the USA, UK, and South Korea.
ZiO Health specializes in the development of innovative biosensor technology that quantitatively analyzes various parameters in bodily and environmental fluids. The company offers a range of portable testing devices tailored for use in homes, hospitals, and other settings, aimed at enhancing health outcomes through molecular testing. Operating under the brands ELAPTA and ELOSIA, ZiO Health provides solutions such as ELOSIA, a home urine test designed to assess wellness parameters and deliver personalized nutrition and wellness advice. The company's devices facilitate the detection and measurement of chemical and biological substances, empowering users to optimize their health and prevent illness through effective home diagnostics and tailored testing solutions.
Sava is a company focused on advancing biosensing technology to enhance personal health monitoring. By providing real-time feedback on the body's molecular signature, particularly for athletes, Sava's technology allows for continuous and effortless monitoring of crucial metrics such as glucose and lactate levels. This capability enables athletes to train more effectively, predict fatigue, and optimize their dietary plans. Sava's innovative approach aims to make health information more accessible, delivering insights in a painless and affordable manner, thereby redefining how individuals interact with their health.
Bubbleye is a rapidly growing AI startup specializing in mobile marketing solutions. With R&D headquarters in Taipei and business development teams operating globally, the company addresses inefficiencies in mobile user acquisition through the use of automation and inferential algorithms. Founded by an international team of AI experts and mobile gaming enthusiasts, Bubbleye boasts a diverse cultural background, drawing talent from Italy, Taiwan, the USA, and the UK. The firm has gained recognition and support from notable investors, including alumni from prominent organizations and accelerators. Its client base includes leading game publishers from the Americas, Europe, and Asia, reflecting its commitment to enhancing mobile marketing performance through innovative technology.
Machine Medicine Limited develops a health monitoring system that uses computer vision and artificial intelligence in order to extract health metrics. The system tracks activities, walking patterns, detects falls and disease signs, and alert families when an intervention is needed. The company was founded in 2014 and is headquartered in London, United Kingdom.
Pushme Inc. is a manufacturer of swappable batteries specifically designed for bicycles, aiming to enhance urban mobility. Founded in 2016 and based in Bath, United Kingdom, the company operates as a subsidiary of Tier Mobility GmbH. Pushme focuses on addressing the challenges of energy distribution for small electric vehicles by establishing a network of battery swap stations. These stations allow local merchants to sell energy, providing convenient and instant recharging solutions across cities. The innovative approach not only supports the adoption of electric bicycles but also empowers individuals with access to electricity to contribute to sustainable transport. The team at Pushme comprises engineers, designers, and operations experts dedicated to developing efficient hardware solutions that improve cycling experiences and facilitate energy management.
Machine Medicine Limited develops a health monitoring system that uses computer vision and artificial intelligence in order to extract health metrics. The system tracks activities, walking patterns, detects falls and disease signs, and alert families when an intervention is needed. The company was founded in 2014 and is headquartered in London, United Kingdom.
Kokoon Technology Limited specializes in the manufacturing of sleep-sensing headphones that utilize EEG brainwave sensing technology to monitor sleep patterns. The company offers a mobile application featuring an audio relaxation library and sleep analysis tools. By employing movement and EEG sensors, Kokoon measures brain activity to provide insights into individual sleep habits. The headphones are equipped with features such as active noise cancellation, noise isolation, and active white noise to enhance the sleep experience. Established in 2013 and headquartered in London, United Kingdom, Kokoon aims to make sleep science more personalized and accessible through innovative sensor technology and data-driven solutions.
Chronomics Ltd, established in 2017 and headquartered in Norwich, United Kingdom, specializes in testing kits and an artificial intelligence platform designed for DNA methylation analysis. The company focuses on monitoring users' health and wellbeing by utilizing epigenetic information derived from DNA. Its offerings include insights into biological age, smoke exposure, metabolic state, health risks, and hereditary intolerances, along with predictions related to eye color. Through its innovative approach, Chronomics aims to provide a comprehensive understanding of individual health profiles.
Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.
Circadia fuses light science with sleep science to help adjust your body clock. Their flagship products include a non-contact sleep tracker for sleep diagnostics and a portable light therapy device for treatment. The devices sync together for an automatic and customised sleep improvement programme. Team from Imperial College London. Accelerated by HAX. Mentored by Johnson & Johnson Innovation. Launching on Kickstarter in March 2017.
CoffeeExchange is a digital platform based in Shanghai, China, that connects coffee farmers directly with roasters, aiming to enhance transparency in the coffee industry. Established in 2018, the company utilizes technology to streamline the green coffee trading process, offering services such as coffee evaluation, logistics, customs clearance, quality inspections, and marketing support. By eliminating intermediaries, CoffeeExchange facilitates direct trade, allowing coffee producers to earn significantly higher revenues while providing roasters with a broader selection at reduced costs. The platform incorporates IoT supply chain tracking and freight consolidation to optimize logistics and enhance order management. Currently, CoffeeExchange has over 1,100 coffee roasters in China trading with selected producers from various countries, including Ethiopia, Rwanda, Ecuador, Colombia, Guatemala, and El Salvador, and is in the process of expanding its operations to the USA, UK, and South Korea.
Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Our co-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. The team has grown to contain commercial expertise that encompasses individuals with a unicon exit in their CV's, as well as multiple startup experience between them. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.